Scott joined Venture Investors in 1996 as an Analyst and became a Managing Director with the firm in 2000, with VIESF III. He has been a Managing Director in all of the firm’s subsequent funds. Scott focuses on investment prospects in medical devices, digital health, and diagnostics.
Scott has over twenty years of portfolio company board experience, including his current directorships at Silatronix, Elucent Medical (founded by NeuWave Medical founders), HealthMyne (founded by a Tomotherapy founder), Eximis Surgical, and EnsoData. He is also a Board Observer for Thalchemy. He uses his network and extensive experience to identify novel technologies in the university ecosystem that have the potential to turn into start-ups. Scott led the original round of financing for NeuWave Medical when the company was comprised of one employee and the four founders. He was instrumental in identifying and recruiting its CEO and second employee at the time of our original investment. NeuWave was acquired by Johnson & Johnson’s Ethicon division for $300 million and was single largest return to any VI fund.
Prior to joining Venture Investors, Scott worked for McDonald’s Corporation as an Operations Manager, and for Rockwell Automation as a Field Sales Engineer in the automotive industry.
In his spare time, Scott enjoys cycling, cross-country skiing (completed 11 American Birkebeiners), fishing, go-kart racing and being with his family.